We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Top Sells

Rank Stock Value
1
LNKD
LinkedIn Corporation
LNKD
+$24.4M
2
PG icon
Procter & Gamble
PG
+$21.2M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$19.7M
4
AA icon
Alcoa
AA
+$17.9M
5
YUM icon
Yum! Brands
YUM
+$15.8M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
I
2801
DELISTED
INTELSAT S. A.
I
$88K ﹤0.01%
32,947
+906
+3% +$2.74K
MN
2802
DELISTED
MANNING & NAPIER, INC.
MN
$86K ﹤0.01%
11,412
-2,571
-18% -$19K
RLH
2803
DELISTED
Red Lions Hotel Corporation
RLH
$86K ﹤0.01%
+10,291
New +$88.7K
ARWR icon
2804
Arrowhead Research
ARWR
$11.9B
$84K ﹤0.01%
54,398
-8,315
-13% -$35.4K
PMBC
2805
DELISTED
Pacific Mercantile Bancorp
PMBC
$83K ﹤0.01%
+11,363
New +$76.5K
TLPH icon
2806
Talphera
TLPH
$66.4M
$82K ﹤0.01%
1,578
-394
-20% -$24.2K
GNE icon
2807
Genie Energy
GNE
$367M
$76K ﹤0.01%
13,184
-2,296
-15% -$13.3K
NEOS
2808
DELISTED
Neos Therapeutics, Inc
NEOS
$76K ﹤0.01%
12,983
+2,878
+28% +$19.5K
NAGE
2809
Niagen Bioscience
NAGE
$271M
$74K ﹤0.01%
22,314
-17,087
-43% -$46.4K
ASXC
2810
DELISTED
Asensus Surgical, Inc.
ASXC
$74K ﹤0.01%
4,367
-105
-2% -$2.15K
FBIO icon
2811
Fortress Biotech
FBIO
$104M
$73K ﹤0.01%
1,803
+201
+13% +$7.51K
VNCE icon
2812
Vince Holding Corp
VNCE
$81.3M
$70K ﹤0.01%
1,735
-119
-6% -$5.67K
LRMR icon
2813
Larimar Therapeutics
LRMR
$397M
$68K ﹤0.01%
1,774
-1,142
-39% -$46.3K
VHI icon
2814
Valhi
VHI
$380M
$67K ﹤0.01%
1,620
-123
-7% -$3.87K
IMDZ
2815
DELISTED
Immune Design Corp.
IMDZ
$67K ﹤0.01%
12,151
+1,652
+16% +$11.7K
AST
2816
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$65K ﹤0.01%
14,050
+1,786
+15% +$7.37K
INFI
2817
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$64K ﹤0.01%
47,625
-34,964
-42% -$45.7K
ALJJ
2818
DELISTED
ALJ Regional Holdings Inc
ALJJ
$63K ﹤0.01%
14,351
-9,443
-40% -$40.4K
TTNP
2819
DELISTED
Titan Pharmaceuticals
TTNP
$60K ﹤0.01%
4
– –
ADVM
2820
DELISTED
Adverum Biotechnologies
ADVM
$58K ﹤0.01%
1,983
-494
-20% -$16.1K
SENS icon
2821
Senseonics Holdings Inc
SENS
$263M
$58K ﹤0.01%
1,094
+125
+13% +$7.15K
TTOO
2822
DELISTED
T2 Biosystems, Inc
TTOO
$55K ﹤0.01%
2
– –
MRTX
2823
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$55K ﹤0.01%
11,629
-1,458
-11% -$7.93K
TPST icon
2824
Tempest Therapeutics
TPST
$13.7M
$53K ﹤0.01%
12
-3
-20% -$37.4K
CRDF icon
2825
Cardiff Oncology
CRDF
$66.5M
$52K ﹤0.01%
346
-207
-37% -$48.3K
111 112
113
114 115

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.